Zobrazeno 1 - 10
of 43 955
pro vyhledávání: '"Lipids"'
Autor:
Jim Mann
Publikováno v:
European Journal of Clinical Nutrition. 55:919-921
Autor:
Josep Lupón, Núria Alonso, Didac Mauricio, Albert Teis, Antoni Bayes-Genis, Marcelino Bermúdez-López, Nuria Amigo, Esmeralda Castelblanco, Germán Cediel, Pau Codina, Josep Julve, Montse Guardiola, Josep Franch, J. Ribalta
Publikováno v:
Revista Española de Cardiología (English Edition). 75:864-873
INTRODUCTION AND OBJECTIVES Advanced lipoprotein phenotyping is a better predictor of atherosclerotic cardiovascular risk than cholesterol concentration alone. Lipoprotein profiling in heart failure (HF) is incompletely characterized. We aimed to des
Autor:
Katelyn M. Kozinski, Michael L. Himes, Brian J. Lopresti, Joseph R. Hibbeln, Matthew F. Muldoon, Rajesh Narendran, N. Scott Mason, Savannah Tollefson
Publikováno v:
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 7:998-1006
Docosahexaenoic acid (DHA) shows anti-inflammatory/proresolution effects in the brain. Higher red blood cell (RBC) DHA in humans is associated with improved cognitive performance and a lower risk for suicide. Here, we hypothesized that binding to the
Autor:
Guy T'Sjoen, Martin den Heijer, Alessandra D. Fisher, Christel J. M. de Blok, Jaap Seidell, Maartje Klaver, Thomas Schreiner, Jos W. R. Twisk, Justine Defreyne, Renée de Mutsert, Daan M. van Velzen, Nota Nienke, Chantal M. Wiepjes
Publikováno v:
The Journal of Clinical Endocrinology and Metabolism
The Journal of clinical endocrinology and metabolism, 107(1), e153-e164. The Endocrine Society
The Journal of clinical endocrinology and metabolism, 107(1), e153-e164. Oxford University Press
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
The Journal of Clinical Endocrinology & Metabolism, 107(1), E153-E164. ENDOCRINE SOC
Klaver, M, van Velzen, D, de Blok, C, Nota, N, Wiepjes, C, Defreyne, J, Schreiner, T, Fisher, A, Twisk, J, Seidell, J, T'Sjoen, G, den Heijer, M & de Mutsert, R 2022, ' Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy ', The Journal of clinical endocrinology and metabolism, vol. 107, no. 1, pp. e153-e164 . https://doi.org/10.1210/clinem/dgab616
Klaver, M, van Velzen, D, de Blok, C, Nota, N, Wiepjes, C, Defreyne, J, Schreiner, T, Fisher, A, Twisk, J, Seidell, J, t'Sjoen, G, den Heijer, M & de Mutsert, R 2022, ' Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy ', The Journal of clinical endocrinology and metabolism, vol. 107, no. 1, pp. e153-e164 . https://doi.org/10.1210/clinem/dgab616
The Journal of clinical endocrinology and metabolism, 107(1), e153-e164. The Endocrine Society
The Journal of clinical endocrinology and metabolism, 107(1), e153-e164. Oxford University Press
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
The Journal of Clinical Endocrinology & Metabolism, 107(1), E153-E164. ENDOCRINE SOC
Klaver, M, van Velzen, D, de Blok, C, Nota, N, Wiepjes, C, Defreyne, J, Schreiner, T, Fisher, A, Twisk, J, Seidell, J, T'Sjoen, G, den Heijer, M & de Mutsert, R 2022, ' Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy ', The Journal of clinical endocrinology and metabolism, vol. 107, no. 1, pp. e153-e164 . https://doi.org/10.1210/clinem/dgab616
Klaver, M, van Velzen, D, de Blok, C, Nota, N, Wiepjes, C, Defreyne, J, Schreiner, T, Fisher, A, Twisk, J, Seidell, J, t'Sjoen, G, den Heijer, M & de Mutsert, R 2022, ' Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy ', The Journal of clinical endocrinology and metabolism, vol. 107, no. 1, pp. e153-e164 . https://doi.org/10.1210/clinem/dgab616
Introduction Excess visceral fat increases the risk of type 2 diabetes and cardiovascular disease and is influenced by sex hormones. Our aim was to investigate changes in visceral fat and the ratio of visceral fat to total body fat (VAT/TBF) and thei
Autor:
David S. Ludwig, Julia M W Wong, Clement Ma, Cara B. Ebbeling, Amy Knapp, Ann Johnson, Samia Mora, Kimberly F. Greco
Publikováno v:
The American Journal of Clinical Nutrition
Background Carbohydrate restriction shows promise for diabetes, but concerns regarding high saturated fat content of low-carbohydrate diets limit widespread adoption. Objectives This preplanned ancillary study aimed to determine how diets varying wid
Publikováno v:
Lymphatic Research and Biology. 20:358-367
Background: Generalized lymphatic anomalies (GLA) are complex vessel malformations that can impair lymphatic function. Potential GLA complications include lipid-rich lymph in the thoracic space or peritoneal cavity, respectively chylothorax and chylo
Autor:
Xianjun Ma, Jing Fu
Publikováno v:
Minerva Medica. 114
Autor:
Klaudia Brix, Georg Sebastian Hönes, Josef Köhrle, Kostja Renko, Lars C. Moeller, Dagmar Führer, Helena Kerp
Publikováno v:
Journal of Molecular Endocrinology. 67:161-172
Thyroid hormone (TH) metabolism and cellular TH action are influenced by ageing. To investigate the response to thyroxine (T4) overtreatment, a kinetic study was conducted in young and aged mice with chronic hyperthyroidism and hormone withdrawal. Fi
Autor:
Saeid Doaei, Vahideh Jalili, Alireza Moslem, Alireza Mosavi Jarrahi, Samira Rastgoo, Sepehr Javadikooshesh, Fatemeh Bourbour, Maryam Gholamalizadeh, Morteza Abdollahi, Azadeh Hajipour, Zohreh Mokhtari
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 13, Iss 1, Pp 1-6 (2021)
Diabetology & Metabolic Syndrome
Diabetology & Metabolic Syndrome
Background FTO gene is considered to play an important role in many metabolic diseases. Evidence from studies indicated the possible association between the FTO rs9939609 polymorphisms with serum lipid profile. Therefore, this study aimed to investig
Autor:
Charles M. Rowland, Carmen H. Tong, Jeff Radcliff, James J. Devlin, Michael J. McPhaul, Lance A. Bare, Yonghong Li
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Scientific Reports
Scientific Reports
In clinical trials, vitamin D supplementation has been reported to reduce serum levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG) but not high-density lipoprotein cholesterol (HDL-C). In this cohort